Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
Comments
Loading...
GlycoMimetics (GLYC) Forecast
NewsEarningsGlycoMimetics (GLYC) OptionsGuidanceDividendsAnalyst RatingsInsider TradesShort InterestEdge Rankings
Stock Score Locked: Want to See it?
Benzinga Rankings give you vital metrics on any stock – anytime.
GlycoMimetics Stock Price, Quotes and Forecasts | NASDAQ:GLYC | Benzinga
Explore GlycoMimetics stock price, quotes, charts and forecasts with Benzinga. Stay updated on market trends for GLYC.
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy GlycoMimetics (GLYC) stock?
You can purchase shares of GlycoMimetics (NASDAQ:GLYC) through any online brokerage.
Who are GlycoMimetics (GLYC) competitors?
Other companies in GlycoMimetics’s space includes: Ernexa Therapeutics (NASDAQ:ERNA), HOOKIPA Pharma (NASDAQ:HOOK), Nanoviricides (AMEX:NNVC), Can Fite Biofarma (AMEX:CANF) and Bolt Biotherapeutics (NASDAQ:BOLT).
What is the forecast, or price target, for GlycoMimetics (GLYC) stock?
GlycoMimetics has a consensus price target of $12.00.
What is the current price for GlycoMimetics (GLYC)?
The stock price for GlycoMimetics (NASDAQ: GLYC) is $0.2485 last updated May 15, 2025 at 11:24 AM EDT.
Does GlycoMimetics (GLYC) pay a dividend?
There are no upcoming dividends for GlycoMimetics.
When is GlycoMimetics (NASDAQ:GLYC) reporting earnings?
GlycoMimetics’s Q2 earnings are confirmed for Friday, August 8, 2025.
Is GlycoMimetics (GLYC) going to split?
There is no upcoming split for GlycoMimetics.
What sector and industry does GlycoMimetics (GLYC) operate in?
GlycoMimetics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
